Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1962 May 5;1(5287):1219–1224. doi: 10.1136/bmj.1.5287.1219

Tranquillizers*

M Weatherall
PMCID: PMC1958542  PMID: 20789399

Full text

PDF
1219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHBY W. R., BASSETT M., COLLINS G. H., TAYLOR A. L. A clinical trial of covatin on elderly patients with anxiety and restlessness. J Ment Sci. 1959 Apr;105(439):504–507. doi: 10.1192/bjp.105.439.504. [DOI] [PubMed] [Google Scholar]
  2. AYD F. J., Jr A survey of drug-induced extrapyramidal reactions. JAMA. 1961 Mar 25;175:1054–1060. doi: 10.1001/jama.1961.03040120016004. [DOI] [PubMed] [Google Scholar]
  3. BAKER A. A., THORPE J. G. Placebo response. AMA Arch Neurol Psychiatry. 1957 Jul;78(1):57–60. doi: 10.1001/archneurpsyc.1957.02330370071011. [DOI] [PubMed] [Google Scholar]
  4. BEECHER H. K., KEATS A. S., MOSTELLER F., LASAGNA L. The effectiveness of oral analgesics (morphine, codeine, acetylsalicylic acid) and the problem of placebo "reactors" and "non-reactors". J Pharmacol Exp Ther. 1953 Dec;109(4):393–400. [PubMed] [Google Scholar]
  5. BEECHER H. K. The powerful placebo. J Am Med Assoc. 1955 Dec 24;159(17):1602–1606. doi: 10.1001/jama.1955.02960340022006. [DOI] [PubMed] [Google Scholar]
  6. BRILL H., PATTON R. E. Analysis of 1955-1956 population fall in New York State mental hospitals in first year of large-scale use of tranquilizing drugs. Am J Psychiatry. 1957 Dec;114(6):509–517. doi: 10.1176/ajp.114.6.509. [DOI] [PubMed] [Google Scholar]
  7. CUTLER R. P., MONROE J. J., ANDERSON T. E. Effects of tranquilizers upon pathological activity in psychotic patients. I. Chlorpromazine. AMA Arch Neurol Psychiatry. 1957 Jun;77(6):616–622. doi: 10.1001/archneurpsyc.1957.02330360074008. [DOI] [PubMed] [Google Scholar]
  8. DICKER S. E., STEINBERG H. The effect of methylpentynol in man. Br J Pharmacol Chemother. 1957 Dec;12(4):479–483. doi: 10.1111/j.1476-5381.1957.tb00169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DIXON W. M., STRADLING P., WOOTTON I. D. Outpatient P.A.S. therapy. Lancet. 1957 Nov 2;273(7001):871–872. doi: 10.1016/s0140-6736(57)90006-5. [DOI] [PubMed] [Google Scholar]
  10. DRANSFIELD G. A. A clinical trial comparing prochlorperazine (stemetil) with chlorpromazine (largactil) in the treatment of chronic psychotic patients. J Ment Sci. 1958 Oct;104(437):1183–1189. doi: 10.1192/bjp.104.437.1183. [DOI] [PubMed] [Google Scholar]
  11. EISEN S. B., SABSHIN M., HEATH H. A comparison of the effects of investigators' and therapists' attitudes in the evaluation of tranquilizers prescribed to hospital patients. J Nerv Ment Dis. 1959 Mar;128(3):256–261. [PubMed] [Google Scholar]
  12. FELDMAN P. E. The personal element in psychiatric research. Am J Psychiatry. 1956 Jul;113(1):52–54. doi: 10.1176/ajp.113.1.52. [DOI] [PubMed] [Google Scholar]
  13. FOULDS G. A. Clinical research in psychiatry. J Ment Sci. 1958 Apr;104(435):259–265. doi: 10.1192/bjp.104.435.259. [DOI] [PubMed] [Google Scholar]
  14. FOX B. The investigation of the effects of psychiatric treatment. J Ment Sci. 1961 May;107:493–502. doi: 10.1192/bjp.107.448.493. [DOI] [PubMed] [Google Scholar]
  15. FULLERTON P. M., KREMER M. Neuropathy after intake of thalidomide (distaval). Br Med J. 1961 Sep 30;2(5256):855–858. doi: 10.1136/bmj.2.5256.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. GOODNOW R. E., BEECHER H. K., BRAZIER M. A. B., MOSTELLER K., TAGIURI R. Physiological performance following a hypnotic dose of a barbiturate. J Pharmacol Exp Ther. 1951 May;102(1):55–61. [PubMed] [Google Scholar]
  17. HAMILTON M., HARGREAVES G. R., ROBERTS J. M. Benactyzine as an aid in treatment of anxiety states; preliminary report. Br Med J. 1957 Feb 9;1(5014):306–310. doi: 10.1136/bmj.1.5014.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HAMPSON J. L., ROSENTHAL D., FRANK J. D. A comparative study of the effect of mephenesin and placebo on the symptomatolog of a mixed group of psychiatric outpatients. Bull Johns Hopkins Hosp. 1954 Oct;95(4):170–177. [PubMed] [Google Scholar]
  19. HEILIZER F. A critical review of some published experiments with chlorpromazine in schizophrenic, neurotic, and normal humans. J Chronic Dis. 1960 Feb;11:102–148. doi: 10.1016/0021-9681(60)90093-x. [DOI] [PubMed] [Google Scholar]
  20. HELLER G. C., WALTON D., BLACK D. A. Meprobamate in the treatment of tension states. J Ment Sci. 1957 Jul;103(432):581–588. doi: 10.1192/bjp.103.432.581. [DOI] [PubMed] [Google Scholar]
  21. HOUSTON F. Group behaviour in chronic schizophrenics treated with meratran. Br Med J. 1956 Apr 28;1(4973):949–952. doi: 10.1136/bmj.1.4973.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. ISBELL H., ALTSCHUL S., KORNETSKY C. H., EISENMAN A. J., FLANARY H. G., FRASER H. F. Chronic barbiturate intoxication; an experimental study. Arch Neurol Psychiatry. 1950 Jul;64(1):1–28. doi: 10.1001/archneurpsyc.1950.02310250007001. [DOI] [PubMed] [Google Scholar]
  23. JOYCE C. R. Consistent differences in individual reactions to drugs and dummies. Br J Pharmacol Chemother. 1959 Dec;14:512–521. doi: 10.1111/j.1476-5381.1959.tb00958.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. KAWI A. A. The sedation threshold: its concept and use for comparative studies on drug-induced phenomena. AMA Arch Neurol Psychiatry. 1958 Aug;80(2):232–236. [PubMed] [Google Scholar]
  25. KELLY E. L., MILLER J. G., MARQUIS D. G., GERARD R. W., UHR L. Personality differences and continued meprobamate and proclorperazine administration. AMA Arch Neurol Psychiatry. 1958 Aug;80(2):241–246. doi: 10.1001/archneurpsyc.1958.02340080111024. [DOI] [PubMed] [Google Scholar]
  26. KORNETSKY C. Effects of meprobamate, phenobarbital and dextroamphetamine on reaction time and learning in man. J Pharmacol Exp Ther. 1958 Jul;123(3):216–219. [PubMed] [Google Scholar]
  27. KORNETSKY C., HUMPHRIES O., EVARTS E. V. Comparison of psychological effects of certain centrally acting drugs in man. AMA Arch Neurol Psychiatry. 1957 Mar;77(3):318–324. doi: 10.1001/archneurpsyc.1957.02330330104016. [DOI] [PubMed] [Google Scholar]
  28. KORNETSKY C., HUMPHRIES O. Psychological effects of centrally acting drugs in man; effects of chlorpromazine secobarbital on visual and motor behaviour. J Ment Sci. 1958 Oct;104(437):1093–1099. doi: 10.1192/bjp.104.437.1093. [DOI] [PubMed] [Google Scholar]
  29. KORNETSKY C., VATES T. S., KESSLER E. K. A comparison of hypnotic and residual psychological effects of single doses of chlorpromazine and secobarbital in man. J Pharmacol Exp Ther. 1959 Sep;127:51–54. [PubMed] [Google Scholar]
  30. KOTEEN H. Use of a "double-blind" study investigating the clinical merits of a new tranquilizing agent. Ann Intern Med. 1957 Nov;47(5):978–989. doi: 10.7326/0003-4819-47-5-978. [DOI] [PubMed] [Google Scholar]
  31. LATIES V. G., WEISS B. A critical review of the efficacy of meprobamate (miltown, equanil) in the treatment of anxiety. J Chronic Dis. 1958 Jun;7(6):500–519. doi: 10.1016/0021-9681(58)90168-1. [DOI] [PubMed] [Google Scholar]
  32. LEMERE F. Habit-forming properties of meprobamate. AMA Arch Neurol Psychiatry. 1956 Aug;76(2):205–206. doi: 10.1001/archneurpsyc.1956.02330260091009. [DOI] [PubMed] [Google Scholar]
  33. LITTLE J. C. A double-blind controlled comparison of the effects of chlorpromazine, barbiturate and a placebo in 142 chronic psychotic in-patients. J Ment Sci. 1958 Apr;104(435):334–349. doi: 10.1192/bjp.104.435.334. [DOI] [PubMed] [Google Scholar]
  34. LLOYD E. A., CLARK L. D. Convulsions and delirium incident to glutethimide (doriden) withdrawal (a case report). Dis Nerv Syst. 1959 Nov;20:524–526. [PubMed] [Google Scholar]
  35. LOOMIS T. A., WEST T. C. Comparative sedative effects of a barbiturate and some tranquilizer drugs on normal subjects. J Pharmacol Exp Ther. 1958 Apr;122(4):525–531. [PubMed] [Google Scholar]
  36. LORANGER A. W., PROUT C. T., WHITE M. A. The placebo effect in psychiatric drug research. JAMA. 1961 Jun 17;176:920–925. doi: 10.1001/jama.1961.03040240026010. [DOI] [PubMed] [Google Scholar]
  37. MARQUIS D. G., KELLY E. L., MILLER J. G., GERARD R. W., RAPOPORT A. Experimental studies of behavioral effects of meprobamate on normal subjects. Ann N Y Acad Sci. 1957 May 9;67(10):701–711. doi: 10.1111/j.1749-6632.1957.tb46007.x. [DOI] [PubMed] [Google Scholar]
  38. MASON A. S., SACKS J. M. Measurement of attitudes toward the tranquilizing drugs. Dis Nerv Syst. 1959 Oct;20:457–459. [PubMed] [Google Scholar]
  39. MELANDER B. Psychotechnische Untersuchungen an Autofahrern unter Medikamenteneinwirkung. Munch Med Wochenschr. 1957 Sep 13;99(37):1340–1342. [PubMed] [Google Scholar]
  40. MERRY J., PARGITER R. A., MUNRO H. Chlorpromazine and chronic neurotic tension. Am J Psychiatry. 1957 May;113(11):988–990. doi: 10.1176/ajp.113.11.988. [DOI] [PubMed] [Google Scholar]
  41. MIRSKY A. F., PRIMAC D. W., BATES R. The effects of chlorpromazine and secobarbital on the C.P.T. J Nerv Ment Dis. 1959 Jan;128(1):12–17. [PubMed] [Google Scholar]
  42. NOWLIS H. H., NOWLIS V. The description and analysis of mood. Ann N Y Acad Sci. 1956 Nov 2;65(4):345–355. doi: 10.1111/j.1749-6632.1956.tb49644.x. [DOI] [PubMed] [Google Scholar]
  44. RASKIN N. Agranulocytosis in patients treated with thorazine; report of a fatal case. Am J Psychiatry. 1957 May;113(11):991–992. doi: 10.1176/ajp.113.11.991. [DOI] [PubMed] [Google Scholar]
  45. REES W. L., LAMBERT C. The value and limitations of chlorpromazine in the treatment of anxiety states. J Ment Sci. 1955 Oct;101(425):834–840. doi: 10.1192/bjp.101.425.834. [DOI] [PubMed] [Google Scholar]
  46. ROBIN A. A. Pecazine ("pacatal") compared with amylobarbitone sodium in anxiety states. J Ment Sci. 1959 Oct;105:1064–1069. doi: 10.1192/bjp.105.441.1064. [DOI] [PubMed] [Google Scholar]
  47. ROGERS G. A. Addiction to glutethimide (doriden). Am J Psychiatry. 1958 Dec;115(6):551–552. doi: 10.1176/ajp.115.6.551. [DOI] [PubMed] [Google Scholar]
  48. SADWIN A., GLEN R. S. Addiction to glutethimide (doriden). Am J Psychiatry. 1958 Nov;115(5):469–470. doi: 10.1176/ajp.115.5.469-a. [DOI] [PubMed] [Google Scholar]
  49. SANTOS L., GROSS M. The clinical effect of norethandrolone on incontinent mental patients. Action induced by nonverbal communication. Am J Psychiatry. 1961 Sep;118:223–226. doi: 10.1176/ajp.118.3.223. [DOI] [PubMed] [Google Scholar]
  50. SEGAL L. J., TANSLEY A. E. A clinical trial with hydroxyzine (atarax) on a group of maladjusted educationally subnormal children. J Ment Sci. 1957 Jul;103(432):677–681. doi: 10.1192/bjp.103.432.677. [DOI] [PubMed] [Google Scholar]
  51. SEGAL M. M., SHAPIRO K. L. A clinical comparison study of the effects of reserpine and placebo on anxiety. AMA Arch Neurol Psychiatry. 1959 Mar;81(3):392–398. doi: 10.1001/archneurpsyc.1959.02340150124016. [DOI] [PubMed] [Google Scholar]
  52. SHAGASS C. The sedation threshold; a method for estimating tension in psychiatric patients. Electroencephalogr Clin Neurophysiol. 1954 May;6(2):221–233. doi: 10.1016/0013-4694(54)90024-3. [DOI] [PubMed] [Google Scholar]
  53. SMITH J. A., GOULDMAN C., RUTHERFORD A., WOLFORD J. Comparison of two phenothiazine derivatives and a barbiturate in chronic schizophrenia. AMA Arch Neurol Psychiatry. 1959 Jan;81(1):97–99. doi: 10.1001/archneurpsyc.1959.02340130117017. [DOI] [PubMed] [Google Scholar]
  54. TUCKER K., WILENSKY H. A clinical evaluation of meprobamate therapy in a chronic schizophrenic population. Am J Psychiatry. 1957 Feb;113(8):698–703. doi: 10.1176/ajp.113.8.698. [DOI] [PubMed] [Google Scholar]
  55. UHLENHUTH E. H., CANTER A., NEUSTADT J. O., PAYSON H. E. The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo. Am J Psychiatry. 1959 Apr;115(10):905–910. doi: 10.1176/ajp.115.10.905. [DOI] [PubMed] [Google Scholar]
  56. WALSH G. P., WALTON D., BLACK D. A. The relative efficacy of vespral and chlorpromazine in the treatment of a group of chronic schizophrenic patients. J Ment Sci. 1959 Jan;105(438):199–209. doi: 10.1192/bjp.105.438.199. [DOI] [PubMed] [Google Scholar]
  57. WEATHERALL M. Discussion on the toxic effects of drugs used in neurological & psychiatric practice. Proc R Soc Med. 1957 Aug;50(8):617–619. [PubMed] [Google Scholar]
  58. WOLF S. Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos. J Clin Invest. 1950 Jan;29(1):100–109. doi: 10.1172/JCI102225. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES